Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 May 17.
Published in final edited form as: Fetal Diagn Ther. 2014 May 17;36(2):154–161. doi: 10.1159/000357841

Prenatal diagnosis of a placental infarction hematoma associated with fetal growth restriction, preeclampsia and fetal death: clinicopathological correlation

Alma Aurioles-Garibay 1,2, Edgar Hernandez-Andrade 1,2, Roberto Romero 1,3,4, Faisal Qureshi 1,5, Hyunyoung Ahn 1,2, Suzanne M Jacques 1,5, Maynor Garcia 1,2, Lami Yeo 1,2, Sonia S Hassan 1,2
PMCID: PMC4166603  NIHMSID: NIHMS602326  PMID: 24852332

Abstract

The lesion termed “placental infarction hematoma” is associated with fetal death and adverse perinatal outcome. Such lesion has been associated with a high risk of fetal death and abruption placentae. The fetal and placental hemodynamic changes associated with placental infarction hematoma have not been reported. This communication describes a case of early and severe growth restriction with preeclampsia, and progressive deterioration of the fetal and placental Doppler parameters in the presence of a placental infarction hematoma.

Keywords: Stillbirth, Placental lesions, Ultrasound, Doppler velocimetry

Introduction

The lesion termed “placental infarction hematoma” is associated with fetal death and adverse perinatal outcome. Such lesion was first described by Bendon [1] when reporting the gross and histopathologic findings of the placenta from six pregnant women, who had spherical blood clots in the placental mass surrounded by infarcted placental tissue. Five of the six cases had a fetal death, and the only surviving fetus was born by emergency cesarean section due to abruptio placentae. The fetal and placental hemodynamic changes associated with placental infarction hematoma have not been reported. This communication describes a case of early and severe growth restriction with preeclampsia, and progressive deterioration of the fetal and placental Doppler parameters in the presence of a placental infarction hematoma.

Case Description

A 20-year old African-American, gravida 3, para 1, abortion 1, with no previous history of chronic diseases, preeclampsia, or fetal growth restriction in the previous pregnancy, was first seen at 8 weeks. The fetal size was appropriate for dates. At 19 weeks and 6 days, the estimated fetal weight was at the 22nd percentile for gestational age, there was normal amniotic fluid, and present end-diastolic velocities in the umbilical artery. There was a bilateral notch in the uterine arteries, and also an increased pulsatility index (PI) bilaterally. A rounded cystic area measuring 13 × 14 mm was observed in the placental mass. Maternal blood pressure was within normal range. At 20 weeks and 5 days, the patient was admitted with severe headache, hypertension, and proteinuria, and was treated with hydralazine and magnesium sulfate. Ultrasound examination showed a live fetus with an estimated fetal weight below the 5th percentile for gestational age, absent end diastolic velocities in the umbilical artery, reversed atrial flow in the ductus venosus, and decreased PI in the middle cerebral artery (MCA). There was reversal of flow during diastole in the aortic isthmus, bilateral uterine notching, and increased uterine artery PI (Figure 1). The placental cyst measured 14.3 mm × 12.7 mm with an echogenic central area; no blood flow was observed inside or around the placental lesion. The amniotic fluid volume was considered to be within normal range, with a largest vertical pocket of 3.5 cm [2]. Due to the early gestational age, conservative management was undertaken.

Figure 1.

Figure 1

Doppler parameters at the time of hospital admission (20 weeks and 5 days) when fetal growth restriction and preeclampsia were diagnosed.

During hospitalization, sonographic examinations were performed daily. There was progressive deterioration of Doppler parameters. The mother remained hypertensive despite treatment with the highest registered blood pressure of 178/103 mm/Hg, and proteinuria of 8.2g/24 hours at 20 weeks and 6 days. At 21 weeks and 4 days a fetal death was diagnosed. The last Doppler examination prior to the diagnosis of fetal death at 21 weeks and 3 days showed signs of severe fetal-placental hemodynamic deterioration such as: reverse diastolic velocities in the umbilical artery [2, 3], biphasic umbilical vein pulsations [4-6], bilateral uterine notching and increased uterine artery PI [7-9], reduced middle cerebral artery PI [10], abnormal ductus venosus waveform with reverse atrial flow [11-13], and reduced intermediate flow between the systolic and diastolic components of the waveform [14], reversed diastolic flow in the aortic isthmus [15-18], and coronary artery vasodilatation [19-21](Figure 2). Representative images of Doppler interrogation of the different vessels are shown in Figure 3. The placental cyst measured 16 × 14 mm with central areas of mixed echodensity (Figures 4a-c); additional small cystic lesions were observed in the placenta (Figure 4d). Labor was induced, and the patient delivered a non-viable female weighing 299g. The autopsy showed a preterm stillborn with no structural anomalies. The mother was discharged three days after delivery with normal blood pressure.

Figure 2.

Figure 2

Doppler parameters before fetal demise (21 weeks and 3 days).

Figure 3.

Figure 3

Changes in the pulsatility index of the umbilical artery (UA), middle cerebral artery (MCA), uterine arteries (Ut Art) and ductus venosus (DV) during hospitalization.

Figure 4.

Figure 4

Progressive changes in the echogenicity of the placental lesion in relation to gestational age (a-c). The area inside the cyst became more echogenic as gestation progressed (arrows). Additional small cystic areas are shown in Figure 4d.

Placental pathology

The placenta weighed 100 grams, and measured 8×7×2 cm. There were three vessels in the umbilical cord. Sections of the placenta showed pale surfaces (Figures 5a and 5b). A cystic hemorrhagic area with a yellow rim, measuring 3×3×2 cm, was observed involving approximately 20% of the placenta. Two additional small yellow lesions were noted, and confirmed to be infarcts on microscopic examination. The largest lesion was a hematoma, surrounded by a rim of infarcted placental tissue. Microscopic evaluation of the placenta also showed persistent muscularization (Figure 5c), atherosis (Figure 5d), persistent endovascular trophoblast, mural hypertrophy and thrombi in decidual vessels, as well as abnormal villous morphology including distal villous hypoplasia (Figure 5e) and foci of villous dysmaturity.

Figure 5.

Figure 5

Pathological examination of the placenta: a) the maternal surface shows an ill-defined yellow area (arrows) which coincided with the infarction hematoma; b) cut sections of the placenta show a large round hemorrhagic lesion surrounded by yellow infarcted placental tissues. Two additional small infarcts (arrows) are also present; c) basal decidual vessels with thick muscularized walls (arrows) and absent physiologic remodeling (persistent muscularization), d) fibrinoid deposition (arrow) in the arterial walls (atherosis), and e) decreased number of distal villi with increased syncytial knots and prominent stem villi.

Comment

This case report shows the rapid deterioration of Doppler parameters in a fetus diagnosed to be growth restricted, and the development of early onset preeclampsia associated with a placental infarction hematoma. In a period of 6 days, there was cessation of fetal growth, and multiple signs of hemodynamic deterioration became apparent. Subsequent sonographic examinations showed worsening of all Doppler parameters consistent with increased impedance to flow in the placenta, abnormal venous Doppler velocimetry, and decreased impedance to flow in the middle cerebral and coronary arteries. The cystic image in the placenta evolved from a predominantly echolucent to a heterogeneous echodense lesion. Acute fetal deterioration may have been associated with the development of the hematoma within the infarcted area of the placenta. The placenta showed extensive lesions of decidual vasculopathy including atherosis and persistent muscularization. Decidual vasculopathy can cause a reduction in utero-placental blood flow leading to placental ischemia, placental infarcts and lesions of placental underperfusion including, increased syncytial knots, and distal villous hypoplasia (22). Two smaller infarcts accompanied the infarction hematoma, reinforcing the probability of severe utero-placental disease. The acute evolution in this case is most likely a result of progressive worsening of utero-placental disease.

The proposed pathophysiology of placental infarction hematoma is occlusion of a spiral artery leading to a placental infarction, and subsequent recanalization of the vessel. This may result in the hematoma within the placental mass [1]. Placental infarction hematoma has been associated with preeclampsia and intrauterine growth restriction. However, only a few cases of these conditions have been reported in the literature. Our impression is that this is due to underreporting. The ultrasound appearance shows an echodense region inside an echolucent area, which can correspond to a recently formed hematoma. Old hematomas within an infarcted area might not be identified by ultrasound, as they tend to appear echolucent with time [23]; a definitive diagnosis can only be made through histopathologic examination of the placenta [24].

Placental infarcts are mainly due to: a) occlusion of spiral arteries by thrombus; b) strangulation of the placental villi due to increased perivillous or intervillous fibrin/fibrinoid deposition; and c) impairment of the fetal circulation due to fetal thrombotic vasculopathy [22, 25-28]. Placental infarcts can be documented in approximately 20% of uncomplicated pregnancies and in 70% and 40% of patients with severe and mild preeclampsia, respectively [29-31]. Vinnars et al. [30] reported that infarcts involving more than 5% of the placenta can be observed in 39% of patients with severe preeclampsia. The association of placental infarctions with acute fetal deterioration was reported by Barclay et al. [32] in a patient at 27 weeks of gestation with acute reduction of amniotic fluid volume, lack of fetal growth, and abnormal fetal heart rate tracing, in the presence of multiple placental cystic areas suggestive of infarcts, which were confirmed after the delivery.

Sonographic images associated with placental lesions include: cystic areas [33-35], heterogeneous appearance of the placental mass [36-39], and thick [40] or thin [41] placentas. Cystic areas are frequently observed in association with preeclampsia, growth restriction and fetal demise [31, 42-46]. Fitzgerald et al. [47] reported that well-defined rounded cystic areas in the placenta were associated with a higher risk of preeclampsia and intrauterine growth restriction. The authors referred to this as “rounded intraplacental haematomas” (RIH) and reported that more than 50% of these cystic lesions were associated with placental infarcts reflecting maternal vascular underperfusion. Viero et al. [48] studied the sonographic placental features of 59 fetuses with absent end diastolic flow in the umbilical artery, and reported cystic images highly suspicious of placental lesions in 43 of 59 pregnancies. Echogenic cystic lesions had a 37% sensitivity for confirmed villous infarcts, and when combined with abnormal uterine artery Doppler velocimetry, there was a 53% positive predictive value for fetal death. The authors emphasized the potential value of other imaging techniques of the placenta such as magnetic resonance imaging (MRI), and the possibility of treatment with heparin. Messerschmidt et al. [49] reported the results of MRI examination of the placenta in 50 patients with early IUGR, abnormal umbilical artery Doppler velocimetry or oligohydramnios. The prevalence of placental infarcts with or without hemorrhage was 35% and 89% for subchorionic thrombi. Fetal death occurred in 36% of cases, and surviving fetuses were delivered at a mean gestational age of 29 weeks. The authors proposed that MRI may have the potential for the prenatal diagnosis of placental infarctions in cases of early placental insufficiency.

Detailed sonographic evaluation of the placenta and histopathological confirmation after birth are used to identify lesions associated with preeclampsia, intrauterine growth restriction and adverse short and long-term perinatal outcome [25, 50-58]. The presence of cystic images in the placenta is not uniformly associated with adverse perinatal outcome [59]. Detailed sonographic evaluation of cysts includes evaluation of shape, size and content as well as the absence/presence of blood flow around or inside the cyst. The presence of hypoechogenic images with a regular shape, with a hyperechogenic rim and the lack of demonstrable blood flow, suggests the presence of placental pathology, and specifically, a placental infarction hematoma [60, 61]. MRI may improve the diagnosis of placental cystic structures [49, 62], and placental vascular lesions consistent with underperfusion and fetal thrombotic vasculopathy have been associated with abnormal neurodevelopment in surviving fetuses [54, 63, 64].

At present, there is no treatment for placental infarction hematomas. Alkazaleh et al. [65] proposed the use of low molecular-weight heparin and aspirin when placental lesions suggestive of infarcts are observed in the ultrasound scan. They evaluated pregnant women at 18-20 weeks of gestation with a history of previous fetal death, preeclampsia and/or IUGR. The authors identified six patients with echogenic cystic areas in the placenta and abnormal uterine artery Doppler, but still with normal fetal growth; all were treated with low molecular-weight heparin (LMWH [Dalteparin], 5–10 000 units/day subcutaneously) and 81 mg of aspirin daily. All patients had a live birth (33 to 37 weeks of gestation). However, the authors did not offer treatment when fetal growth restriction was diagnosed. The study of Alkazaleh et al. [65] is interesting and suggests that the identification of placental lesions with ultrasound in the absence of fetal growth restriction may be amenable to treatment. However, this concept requires additional studies.

Conclusion

We report the sonographic findings and Doppler velocimetry in a case of placental infarction hematoma associated with adverse perinatal outcome

Established Facts

Already known fact 1; Placental infarcts can be manifested as placental cystic lesions.

Already known fact 2; Preeclampsia and intrauterine growth restriction can be associated with placental cysts.

Novel Insights

New information 1; Ultrasound characteristics of a placental cystic lesion might suggest the presence of a hematoma within an infarcted placental area.

New information 2; Acute fetal hemodynamic deterioration can be related with the progressive development of a hematoma within the cystic lesion.

Acknowledgments

This research was supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); and, in part, with Federal funds from NICHD, NIH under Contract No. HSN275201300006C.

References

  • 1.Bendon RW. Nosology: Infarction hematoma, a placental infarction encasing a hematoma. Hum Pathol. 2012;43:761–763. doi: 10.1016/j.humpath.2011.07.023. [DOI] [PubMed] [Google Scholar]
  • 2.Gudmundsson S, Lindblad A, Marsal K. Cord blood gases and absence of end-diastolic blood velocities in the umbilical artery. Early Hum Dev. 1990;24:231–237. doi: 10.1016/0378-3782(90)90030-m. [DOI] [PubMed] [Google Scholar]
  • 3.Ferrazzi E, Bozzo M, Rigano S, Bellotti M, Morabito A, Pardi G, Battaglia FC, Galan HL. Temporal sequence of abnormal doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol. 2002;19:140–146. doi: 10.1046/j.0960-7692.2002.00627.x. [DOI] [PubMed] [Google Scholar]
  • 4.Rizzo G, Capponi A, Soregaroli M, Arduini D, Romanini C. Umbilical vein pulsations and acid-base status at cordocentesis in growth-retarded fetuses with absent end-diastolic velocity in umbilical artery. Biol Neonate. 1995;68:163–168. doi: 10.1159/000244233. [DOI] [PubMed] [Google Scholar]
  • 5.Hofstaetter C, Dubiel M, Gudmundsson S. Two types of umbilical venous pulsations and outcome of high-risk pregnancy. Early Hum Dev. 2001;61:111–117. doi: 10.1016/s0378-3782(00)00126-2. [DOI] [PubMed] [Google Scholar]
  • 6.Cheema R, Bayoumi MZ, Gudmundsson S. Multivascular doppler surveillance in high risk pregnancies. J Matern Fetal Neonatal Med. 2012;25:970–974. doi: 10.3109/14767058.2011.602141. [DOI] [PubMed] [Google Scholar]
  • 7.Gudmundsson S, Korszun P, Olofsson P, Dubiel M. New score indicating placental vascular resistance. Acta Obstet Gynecol Scand. 2003;82:807–812. doi: 10.1034/j.1600-0412.2003.00203.x. [DOI] [PubMed] [Google Scholar]
  • 8.Hernandez-Andrade E, Brodszki J, Lingman G, Gudmundsson S, Molin J, Marsal K. Uterine artery score and perinatal outcome. Ultrasound Obstet Gynecol. 2002;19:438–442. doi: 10.1046/j.1469-0705.2002.00665.x. [DOI] [PubMed] [Google Scholar]
  • 9.Jamal A, Abbasalizadeh F, Vafaei H, Marsoosi V, Eslamian L. Multicenter screening for adverse pregnancy outcomes by uterine artery doppler in the second and third trimester of pregnancy. Med Ultrason. 2013;15:95–100. doi: 10.11152/mu.2013.2066.152.aj1fa2. [DOI] [PubMed] [Google Scholar]
  • 10.Dubiel M, Gudmundsson S, Gunnarsson G, Marsal K. Middle cerebral artery velocimetry as a predictor of hypoxemia in fetuses with increased resistance to blood flow in the umbilical artery. Early Hum Dev. 1997;47:177–184. doi: 10.1016/s0378-3782(96)01777-x. [DOI] [PubMed] [Google Scholar]
  • 11.Kiserud T, Eik-Nes SH, Blaas HG, Hellevik LR, Simensen B. Ductus venosus blood velocity and the umbilical circulation in the seriously growth-retarded fetus. Ultrasound Obstet Gynecol. 1994;4:109–114. doi: 10.1046/j.1469-0705.1994.04020109.x. [DOI] [PubMed] [Google Scholar]
  • 12.Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackeloer BJ, Kok HJ, Senat MV, Visser GH. Monitoring of fetuses with intrauterine growth restriction: A longitudinal study. Ultrasound Obstet Gynecol. 2001;18:564–570. doi: 10.1046/j.0960-7692.2001.00590.x. [DOI] [PubMed] [Google Scholar]
  • 13.Turan OM, Turan S, Berg C, Gembruch U, Nicolaides KH, Harman CR, Baschat AA. Duration of persistent abnormal ductus venosus flow and its impact on perinatal outcome in fetal growth restriction. Ultrasound Obstet Gynecol. 2011;38:295–302. doi: 10.1002/uog.9011. [DOI] [PubMed] [Google Scholar]
  • 14.Baschat AA, Turan OM, Turan S. Ductus venosus blood-flow patterns: More than meets the eye? Ultrasound Obstet Gynecol. 2012;39:598–599. doi: 10.1002/uog.10151. [DOI] [PubMed] [Google Scholar]
  • 15.Sonesson SE, Fouron JC. Doppler velocimetry of the aortic isthmus in human fetuses with abnormal velocity waveforms in the umbilical artery. Ultrasound Obstet Gynecol. 1997;10:107–111. doi: 10.1046/j.1469-0705.1997.10020107.x. [DOI] [PubMed] [Google Scholar]
  • 16.Fouron JC. The unrecognized physiological and clinical significance of the fetal aortic isthmus. Ultrasound Obstet Gynecol. 2003;22:441–447. doi: 10.1002/uog.911. [DOI] [PubMed] [Google Scholar]
  • 17.Figueras F, Benavides A, Del Rio M, Crispi F, Eixarch E, Martinez JM, Hernandez-Andrade E, Gratacos E. Monitoring of fetuses with intrauterine growth restriction: Longitudinal changes in ductus venosus and aortic isthmus flow. Ultrasound Obstet Gynecol. 2009;33:39–43. doi: 10.1002/uog.6278. [DOI] [PubMed] [Google Scholar]
  • 18.Hernandez-Andrade E, Crispi F, Benavides-Serralde JA, Plasencia W, Diesel HF, Eixarch E, Acosta-Rojas R, Figueras F, Nicolaides K, Gratacos E. Contribution of the myocardial performance index and aortic isthmus blood flow index to predicting mortality in preterm growth-restricted fetuses. Ultrasound Obstet Gynecol. 2009;34:430–436. doi: 10.1002/uog.7347. [DOI] [PubMed] [Google Scholar]
  • 19.Chaoui R. The fetal ‘heart-sparing effect’ detected by the assessment of coronary blood flow: A further ominous sign of fetal compromise. Ultrasound Obstet Gynecol. 1996;7:5–9. doi: 10.1046/j.1469-0705.1996.07010005.x. [DOI] [PubMed] [Google Scholar]
  • 20.Baschat AA, Gembruch U, Gortner L, Reiss I, Weiner CP, Harman CR. Coronary artery blood flow visualization signifies hemodynamic deterioration in growth-restricted fetuses. Ultrasound Obstet Gynecol. 2000;16:425–431. doi: 10.1046/j.1469-0705.2000.00237.x. [DOI] [PubMed] [Google Scholar]
  • 21.Rizzo G, Capponi A, Pietrolucci ME, Boccia C, Arduini D. The significance of visualising coronary blood flow in early onset severe growth restricted fetuses with reverse flow in the ductus venosus. J Matern Fetal Neonatal Med. 2009;22:547–551. doi: 10.1080/14767050902801777. [DOI] [PubMed] [Google Scholar]
  • 22.Fox H, Sebire N. Macroscopic Abnormalities of the Placenta. In: Fox H, Sebire N, editors. Pathology of the Placenta. Philadelphia USA: Saunders Elseviere; 2007. pp. 95–146. [Google Scholar]
  • 23.Nyberg DA, Cyr DR, Mack LA, Wilson DA, Shuman WP. Sonographic spectrum of placental abruption. AJR Am J Roentgenol. 1987;148:161–164. doi: 10.2214/ajr.148.1.161. [DOI] [PubMed] [Google Scholar]
  • 24.Nguyen D, Nguyen C, Yacobozzi M, Bsat F, Rakita D. Imaging of the placenta with pathologic correlation. Semin Ultrasound CT MR. 2012;33:65–77. doi: 10.1053/j.sult.2011.10.003. [DOI] [PubMed] [Google Scholar]
  • 25.Brosens I, Renaer M. On the pathogenesis of placental infarcts in pre-eclampsia. J Obstet Gynaecol Br Commonw. 1972;79:794–799. doi: 10.1111/j.1471-0528.1972.tb12922.x. [DOI] [PubMed] [Google Scholar]
  • 26.Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, Kim CJ, Hassan SS. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med. 2011;39:641–652. doi: 10.1515/JPM.2011.098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Romero R, Kusanovic JP, Kim CJ. Placental Bed Disorders in the Genesis of the Great Obstetrical Syndromes. In: Pijnenborg R, Brosens I, Romero R, editors. Placental Bed Disorders. New Your USA: Cambridge University Press; 2010. pp. 271–289. [Google Scholar]
  • 28.Kraus FT, Redline RW, Gersell DJ, Nelson DM, Dicke JM. Circulatory problems: Thrombi and other vascular lesions. In: K DW, editor. Placental Pathology. Washington, DC: American Registry of Pathology; 2004. p. 123. [Google Scholar]
  • 29.Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol. 2003;189:1173–1177. doi: 10.1067/s0002-9378(03)00576-3. [DOI] [PubMed] [Google Scholar]
  • 30.Vinnars MT, Nasiell J, Ghazi S, Westgren M, Papadogiannakis N. The severity of clinical manifestations in preeclampsia correlates with the amount of placental infarction. Acta Obstet Gynecol Scand. 2011;90:19–25. doi: 10.1111/j.1600-0412.2010.01012.x. [DOI] [PubMed] [Google Scholar]
  • 31.Krielessi V, Papantoniou N, Papageorgiou I, Chatzipapas I, Manios E, Zakopoulos N, Antsaklis A. Placental pathology and blood pressure's level in women with hypertensive disorders in pregnancy. Obstet Gynecol Int. 2012;2012:684083. doi: 10.1155/2012/684083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Barclay D, Evans K, Fox R. Ultrasound-diagnosed placental infarction in a woman with recurrent fetal growth restriction. J Obstet Gynaecol. 2005;25:200–201. doi: 10.1080/01443610500051825. [DOI] [PubMed] [Google Scholar]
  • 33.Harris RD, Cho C, Wells WA. Sonography of the placenta with emphasis on pathological correlation. Semin Ultrasound CT MR. 1996;17:66–89. doi: 10.1016/s0887-2171(96)90045-1. [DOI] [PubMed] [Google Scholar]
  • 34.Brown DL, DiSalvo DN, Frates MC, Davidson KM, Genest DR. Placental surface cysts detected on sonography: Histologic and clinical correlation. J Ultrasound Med. 2002;21:641–646. doi: 10.7863/jum.2002.21.6.641. [DOI] [PubMed] [Google Scholar]
  • 35.Proctor LK, Whittle WL, Keating S, Viero S, Kingdom JC. Pathologic basis of echogenic cystic lesions in the human placenta: Role of ultrasound-guided wire localization. Placenta. 2010;31:1111–1115. doi: 10.1016/j.placenta.2010.10.006. [DOI] [PubMed] [Google Scholar]
  • 36.Chen KH, Chen LR, Lee YH. Exploring the relationship between preterm placental calcification and adverse maternal and fetal outcome. Ultrasound Obstet Gynecol. 2011;37:328–334. doi: 10.1002/uog.7733. [DOI] [PubMed] [Google Scholar]
  • 37.Theophilou G, Sahashrabudhe N, Martindale EA, Heazell AE. Correlation between abnormal placental appearance at routine 2nd trimester ultrasound scan and histological examination of the placenta after birth. J Obstet Gynaecol. 2012;32:760–763. doi: 10.3109/01443615.2012.702149. [DOI] [PubMed] [Google Scholar]
  • 38.Soto E, Romero R, Kusanovic JP, Ogge G, Hussein Y, Yeo L, Hassan SS, Kim CJ, Chaiworapongsa T. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med. 2012;25:498–507. doi: 10.3109/14767058.2011.591461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Whitten AE, Romero R, Korzeniewski SJ, Tarca AL, Schwartz AG, Yeo L, Dong Z, Hassan SS, Chaiworapongsa T. Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): A placental lesion associated with recurrent miscarriage and fetal death. Am J Obstet Gynecol. 2013;208:310e1–310e311. doi: 10.1016/j.ajog.2013.01.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Raio L, Ghezzi F, Cromi A, Nelle M, Durig P, Schneider H. The thick heterogeneous (jellylike) placenta: A strong predictor of adverse pregnancy outcome. Prenat Diagn. 2004;24:182–188. doi: 10.1002/pd.828. [DOI] [PubMed] [Google Scholar]
  • 41.Shukunami K, Nishijima K, Kurokawa T, Tajima K, Kamitani N, Yoshida Y, Kotsuji F. A small-angled thin edge of the placenta predicts abnormal placentation at delivery. J Ultrasound Med. 2005;24:331–335. [PubMed] [Google Scholar]
  • 42.Laurini R, Laurin J, Marsal K. Placental histology and fetal blood flow in intrauterine growth retardation. Acta Obstet Gynecol Scand. 1994;73:529–534. doi: 10.3109/00016349409006268. [DOI] [PubMed] [Google Scholar]
  • 43.Salafia CM, Minior VK, Pezzullo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: Associated placental pathologic features. Am J Obstet Gynecol. 1995;173:1049–1057. doi: 10.1016/0002-9378(95)91325-4. [DOI] [PubMed] [Google Scholar]
  • 44.Roberts DJ, Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol. 2008;61:1254–1260. doi: 10.1136/jcp.2008.055236. [DOI] [PubMed] [Google Scholar]
  • 45.Cooley SM, Donnelly JC, Walsh T, McMahon C, Gillan J, Geary MP. The impact of ultrasonographic placental architecture on antenatal course, labor and delivery in a low-risk primigravid population. J Matern Fetal Neonatal Med. 2011;24:493–497. doi: 10.3109/14767058.2010.497877. [DOI] [PubMed] [Google Scholar]
  • 46.Vedmedovska N, Rezeberga D, Teibe U, Melderis I, Donders GG. Placental pathology in fetal growth restriction. Eur J Obstet Gynecol Reprod Biol. 2011;155:36–40. doi: 10.1016/j.ejogrb.2010.11.017. [DOI] [PubMed] [Google Scholar]
  • 47.Fitzgerald B, Shannon P, Kingdom J, Keating S. Rounded intraplacental haematomas due to decidual vasculopathy have a distinctive morphology. J Clin Pathol. 2011;64:729–732. doi: 10.1136/jcp.2010.087916. [DOI] [PubMed] [Google Scholar]
  • 48.Viero S, Chaddha V, Alkazaleh F, Simchen MJ, Malik A, Kelly E, Windrim R, Kingdom JC. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta. 2004;25:735–741. doi: 10.1016/j.placenta.2004.03.002. [DOI] [PubMed] [Google Scholar]
  • 49.Messerschmidt A, Baschat A, Linduska N, Kasprian G, Brugger PC, Bauer A, Weber M, Prayer D. Magnetic resonance imaging of the placenta identifies placental vascular abnormalities independently of doppler ultrasound. Ultrasound Obstet Gynecol. 2011;37:717–722. doi: 10.1002/uog.8891. [DOI] [PubMed] [Google Scholar]
  • 50.Jauniaux E, Campbell S. Ultrasonographic assessment of placental abnormalities. Am J Obstet Gynecol. 1990;163:1650–1658. doi: 10.1016/0002-9378(90)90645-n. [DOI] [PubMed] [Google Scholar]
  • 51.Rodriguez JG, Porter HJ, Andrews HS, Soothill PW. Placental lesions: Is growth a predictor of bad outcome? Fetal Diagn Ther. 1997;12:163–166. doi: 10.1159/000264459. [DOI] [PubMed] [Google Scholar]
  • 52.Kojima K, Suzuki Y, Makino A, Murakami I, Suzumori K. A case of massive subchorionic thrombohematoma diagnosed by ultrasonography and magnetic resonance imaging. Fetal Diagn Ther. 2001;16:57–60. doi: 10.1159/000053882. [DOI] [PubMed] [Google Scholar]
  • 53.Redline RW, Minich N, Taylor HG, Hack M. Placental lesions as predictors of cerebral palsy and abnormal neurocognitive function at school age in extremely low birth weight infants (<1 kg) Pediatr Dev Pathol. 2007;10:282–292. doi: 10.2350/06-12-0203.1. [DOI] [PubMed] [Google Scholar]
  • 54.Redline RW. Placental pathology: A systematic approach with clinical correlations. Placenta. 2008;29(Suppl A):S86–91. doi: 10.1016/j.placenta.2007.09.003. [DOI] [PubMed] [Google Scholar]
  • 55.Yeo L, Ananth C, Vintzileos AM. Placental Abruption. In: Bloomer D, Arulkumaran S, editors. The Global Library of Women's Medicine. 2008. 10.3843/GLOWM.10122. [Google Scholar]
  • 56.Brosens I, Pijnenborg R, Vercruysse L, Romero R. The “great obstetrical syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204:193–201. doi: 10.1016/j.ajog.2010.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Romero R, Whitten A, Korzeniewski SJ, Than NG, Chaemsaithong P, Miranda J, Dong Z, Hassan SS, Chaiworapongsa T. Maternal floor infarction/massive perivillous fibrin deposition: A manifestation of maternal antifetal rejection? Am J Reprod Immunol. 2013;70:285–298. doi: 10.1111/aji.12143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Tuuli MG, Odibo AO. Ultrasound Imaging and Doppler Studies of the Placenta. In: Kay HH, Nelson DM, Wang Y, editors. The placenta from Development to Disease. Oxford, UK, NJ, USA: Blackwell Publishing Ltd; 2011. pp. 122–130. [Google Scholar]
  • 59.Reis NS, Brizot ML, Schultz R, Nomura RM, Zugaib M. Placental lakes on sonographic examination: Correlation with obstetric outcome and pathologic findings. J Clin Ultrasound. 2005;33:67–71. doi: 10.1002/jcu.20086. [DOI] [PubMed] [Google Scholar]
  • 60.Kofinas A, Kofinas G, Sutija V. The role of second trimester ultrasound in the diagnosis of placental hypoechoic lesions leading to poor pregnancy outcome. J Matern Fetal Neonatal Med. 2007;20:859–866. doi: 10.1080/14767050701670191. [DOI] [PubMed] [Google Scholar]
  • 61.Blair E, de Groot J, Nelson KB. Placental infarction identified by macroscopic examination and risk of cerebral palsy in infants at 35 weeks of gestational age and over. Am J Obstet Gynecol. 2011;205:124, e121–127. doi: 10.1016/j.ajog.2011.05.022. [DOI] [PubMed] [Google Scholar]
  • 62.Dekan S, Linduska N, Kasprian G, Prayer D. MRI of the placenta - a short review. Wien Med Wochenschr. 2012;162:225–228. doi: 10.1007/s10354-012-0073-4. [DOI] [PubMed] [Google Scholar]
  • 63.Perrone S, Toti P, Toti MS, Badii S, Becucci E, Gatti MG, Marzocchi B, Picardi A, Buonocore G. Perinatal outcome and placental histological characteristics: A single-center study. J Matern Fetal Neonatal Med. 2012;25(Suppl 1):110–113. doi: 10.3109/14767058.2012.664344. [DOI] [PubMed] [Google Scholar]
  • 64.Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol. 2005;192:452–457. doi: 10.1016/j.ajog.2004.07.030. [DOI] [PubMed] [Google Scholar]
  • 65.Alkazaleh F, Viero S, Simchen M, Walker M, Smith G, Laskin C, Windrim R, Kingdom J. Ultrasound diagnosis of severe thrombotic placental damage in the second trimester: An observational study. Ultrasound Obstet Gynecol. 2004;23:472–476. doi: 10.1002/uog.1044. [DOI] [PubMed] [Google Scholar]

RESOURCES